Literature DB >> 3383773

Effects of glutathione on iodothyronine 5'-deiodinase activity.

A Goswami1, I N Rosenberg.   

Abstract

At nanomolar substrate levels, physiological concentrations (less than or equal to 5 mM) of glutathione (GSH) activate a low Km iodothyronine 5'-deiodinase (I-5'D) activity in renal and hepatic microsomes, but not the low Km (type II) I-5'D in the pituitary, cerebral cortex, or brown adipose tissue. The latter enzyme as well as the type I enzyme activity at micromolar substrate concentrations required higher (greater than 10 mM) concentrations of GSH. However, GSH appeared to interact with the type I and type II enzymes even at subactivation levels, since it inhibited the activation of these enzymes by dithiothreitol (DTT). Activation of the renal and hepatic low Km I-5'D by GSH resembled that by DTT in 1) the similarity of Km values for both T4 (20 nM) and rT3 (2 nM), 2) the catalytic mechanism (ordered sequential with the iodothyronine as the second substrate), 3) the values for activation energies, and 4) sensitivity to inhibition by propylthiouracil. However, the low Km I-5'D activated by GSH was about 10-fold more sensitive to inhibition by iopanoate than when activated by DTT. The responsiveness of the low Km I-5'D's in renal and hepatic microsomes to physiological concentrations of GSH suggests their participation in the metabolism of iodothyronines in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3383773     DOI: 10.1210/endo-123-1-192

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex- and strain-dependent effects.

Authors:  Z L Sulkowski; T Chen; S Midha; A M Zavacki; Elizabeth M Sajdel-Sulkowska
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

2.  Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells.

Authors:  Iuri Martin Goemann; Balázs Gereben; John W Harney; Bo Zhu; Ana Luiza Maia; P Reed Larsen
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

3.  Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis.

Authors:  Marisa Eisenberg; Mary Samuels; Joseph J DiStefano
Journal:  Thyroid       Date:  2008-10       Impact factor: 6.568

4.  Knockdown of the type 3 iodothyronine deiodinase (D3) interacting protein peroxiredoxin 3 decreases D3-mediated deiodination in intact cells.

Authors:  Goele Aerts; Rafael Arrojo E Drigo; Stijn L J Van Herck; Eva Sammels; Delphine Mirebeau-Prunier; Balázs Gereben; Anikó Zeöld; John W Harney; Stephen A Huang; Michelle A Mulcahey; Serge Van der Geyten; Gert Van den Bergh; Lut Arckens; Veerle M Darras; Ann Marie Zavacki
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.